AU2001253870A1 - Receptor-binding compounds and methods for identifying them - Google Patents

Receptor-binding compounds and methods for identifying them

Info

Publication number
AU2001253870A1
AU2001253870A1 AU2001253870A AU5387001A AU2001253870A1 AU 2001253870 A1 AU2001253870 A1 AU 2001253870A1 AU 2001253870 A AU2001253870 A AU 2001253870A AU 5387001 A AU5387001 A AU 5387001A AU 2001253870 A1 AU2001253870 A1 AU 2001253870A1
Authority
AU
Australia
Prior art keywords
protein
molecule
coupled receptor
binding
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253870A
Other languages
English (en)
Inventor
John J. Nestor
Carol J. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consensus Pharmaceuticals Inc
Original Assignee
Consensus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/813,448 external-priority patent/US20020142346A1/en
Priority claimed from US09/813,653 external-priority patent/US20020064770A1/en
Priority claimed from US09/813,651 external-priority patent/US20030018438A1/en
Application filed by Consensus Pharmaceuticals Inc filed Critical Consensus Pharmaceuticals Inc
Publication of AU2001253870A1 publication Critical patent/AU2001253870A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
AU2001253870A 2000-03-21 2001-03-21 Receptor-binding compounds and methods for identifying them Abandoned AU2001253870A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US19094600P 2000-03-21 2000-03-21
US19099600P 2000-03-21 2000-03-21
US19129900P 2000-03-21 2000-03-21
US60/190,946 2000-03-21
US60/191,299 2000-03-21
US60/190,996 2000-03-21
US09/813,448 US20020142346A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,653 US20020064770A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,653 2001-03-20
US09/813,651 US20030018438A1 (en) 2000-03-21 2001-03-20 Binding compounds and methods for identifying binding compounds
US09/813,651 2001-03-20
US09/813,448 2001-03-20
PCT/US2001/040345 WO2001070765A1 (fr) 2000-03-21 2001-03-21 Composes de liaison avec un recepteur et leurs methodes d'identification

Publications (1)

Publication Number Publication Date
AU2001253870A1 true AU2001253870A1 (en) 2001-10-03

Family

ID=27558818

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2001247675A Abandoned AU2001247675A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds
AU2001253870A Abandoned AU2001253870A1 (en) 2000-03-21 2001-03-21 Receptor-binding compounds and methods for identifying them
AU2001247674A Abandoned AU2001247674A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2001247675A Abandoned AU2001247675A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001247674A Abandoned AU2001247674A1 (en) 2000-03-21 2001-03-21 Binding compounds and methods for identifying binding compounds

Country Status (5)

Country Link
EP (3) EP1268521A1 (fr)
JP (2) JP2004502134A (fr)
AU (3) AU2001247675A1 (fr)
CA (3) CA2404139A1 (fr)
WO (3) WO2001070768A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056581A2 (fr) * 2003-12-10 2005-06-23 Universite De Lausanne Peptide susceptible de se lier specifiquement a un recepteur de chimiokine et son utilisation
EP1797428A1 (fr) * 2004-10-04 2007-06-20 Alchemia Pty Ltd Inhibiteurs sélectifs
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
US8409837B2 (en) * 2010-08-19 2013-04-02 Probiodrug Ag Crystal structure of glutaminyl cyclase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532167A (en) * 1994-01-07 1996-07-02 Beth Israel Hospital Substrate specificity of protein kinases

Also Published As

Publication number Publication date
EP1268523A2 (fr) 2003-01-02
WO2001071346A3 (fr) 2002-09-12
JP2004502134A (ja) 2004-01-22
CA2403784A1 (fr) 2001-09-27
WO2001070765A9 (fr) 2003-02-06
WO2001070765A1 (fr) 2001-09-27
CA2404139A1 (fr) 2001-09-27
EP1268520A2 (fr) 2003-01-02
EP1268521A1 (fr) 2003-01-02
JP2003528319A (ja) 2003-09-24
WO2001071346A2 (fr) 2001-09-27
WO2001070768A3 (fr) 2002-03-14
AU2001247674A1 (en) 2001-10-03
WO2001070768A2 (fr) 2001-09-27
AU2001247675A1 (en) 2001-10-03
CA2403788A1 (fr) 2001-09-27

Similar Documents

Publication Publication Date Title
KR20010086040A (ko) 사람의 오르판 ｇ 단백질과 커플링된 수용체
JP2004121225A (ja) 副甲状腺ホルモンのレセプターとそれをコードしているｄｎａ
JPH10508486A (ja) 修飾神経ペプチドｙレセプター
US7108991B2 (en) Human orphan G protein-coupled receptors
US6448377B1 (en) Modified G protein sunbunits
JP2000060578A (ja) 新規ｇ―タンパク質結合レセプタ―（ｈｆｇａｎ７２ｘ）
US20020142346A1 (en) Binding compounds and methods for identifying binding compounds
US20020064770A1 (en) Binding compounds and methods for identifying binding compounds
AU718311B2 (en) A C5a-like seven transmembrane receptor
JP2002507892A (ja) ヒト・アデニル酸シクラーゼのクローニングおよび特性評価
Hawtin et al. Critical role of a subdomain of the N-terminus of the V1a vasopressin receptor for binding agonists but not antagonists; functional rescue by the oxytocin receptor N-terminus
WO2002057313A2 (fr) Composes de liaison et procedes d'identification de ces derniers
AU2001253870A1 (en) Receptor-binding compounds and methods for identifying them
US20030167129A1 (en) Binding compounds and methods for identifying binding compounds
JP2002514926A (ja) ヒト・アデニル酸シクラーゼのクローニングおよび特性評価
US20030018438A1 (en) Binding compounds and methods for identifying binding compounds
US20070122878A1 (en) Human orphan G protein-coupled receptors
CA2193809A1 (fr) Recepteurs modifies lies a des proteines g
US20020192711A1 (en) Methods for identifying ligands of G-Protein-Coupled receptors
CA2252369A1 (fr) Antagonistes peptidiques derives des domaines transmembranaires des recepteurs couples aux proteines g
WO2001027153A1 (fr) Récepteur transmembranaire murin à sept régions, mus musculus mhneaa81
JP4768946B2 (ja) ヒトｇタンパク質共役型受容体の内因性および非内因性型
USRE42190E1 (en) Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
WO2002083934A1 (fr) Recepteur p2yac implique dans l'agregation plaquettaire
WO2001014883A1 (fr) Methode de criblage